HGR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
|John Rogers 161,420 sh (New)|
HOTCHKIS & WILEY 2,040,900 sh (+133.35%)
Paul Tudor Jones 17,600 sh (+109.52%)
|John Keeley Sold Out|
|HOTCHKIS & WILEY 3,416,494 sh (+67.40%)|
John Rogers 253,785 sh (+57.22%)
|HOTCHKIS & WILEY 3,416,494 sh (unchged)||Paul Tudor Jones 12,563 sh (-28.62%)|
|HOTCHKIS & WILEY 3,735,078 sh (+9.32%)|
HOTCHKIS & WILEY 3,663,594 sh (+7.23%)
|Paul Tudor Jones Sold Out|
John Rogers 211,755 sh (-16.56%)
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
HGR' s 10-Year P/S Range
Min: 0 Med: 0.00 Max: 0.47
|Industry:||Health Care Providers » Medical Care|
|Compare:||CHE, FMS, DVA, FSNUY, BDUUF » details|
|Traded in other countries:||HO8.Germany,|
|Hanger Inc was incorporated on March 3, 1988. The Company is a provider of services and products that enhance human physical capabilities. It provides orthotic and prosthetic patient-care services, distributes O&P devices and components, manages O&P networks, and provides therapeutic solutions to the broader post acute market. It has two operating segments: Patient Care and Products & Services. Patient Care segment is comprised of Hanger Clinic, Cares, Dosteon, other related O&P businesses and its contracting network management business. Through this segment, it is the owner and operator of orthotic and prosthetic patient care clinics in the United States and manages an O&P provider network of approximately 1,150 clinics that coordinates all aspects of O&P patient care for insurance companies. It operates in excess of 740 O&P patient care clinics located in 45 states and the District of Columbia. Products & Services segment is comprised of its distribution business, one of the largest distributors of O&P products in the United States, and its rehabilitative solutions business. Its distribution facilities in California, Florida, Georgia, Illinois, Pennsylvania and Texas allow it to deliver products to the vast majority of its distribution customers in the United States within two business days. Its rehabilitative solutions business develops specialized rehabilitation technologies and is a leading provider of evidence-based clinical programs for post-acute rehabilitation, serving more than 4,200 long-term care facilities and other sub-acute rehabilitation providers throughout the United States. This segment also develops neuromuscular technologies through independent research. The Patient Care segment competes with numerous small independent O&P providers for referrals from physicians, therapists, employers, HMOs, PPOs, hospitals, rehabilitation centers, out-patient clinics and insurance companies on both a local and regional basis. It competes with other patient care service providers, including device manufacturers that have independent sales forces, on the basis of quality and timeliness of patient care, location of patient care clinics and pricing for services. The Products & Services segment competes with other distributors, manufactures who sell their products directly, and providers of equipment and services on a regional and national basis that have similar sales forces and products. Some of its distributor competitors are also dedicated to the O&P industry, but many others are large medical product distributors who also distribute O&P products, particularly orthotic products. The Company is subject to a variety of federal, state and local governmental regulations.|
|John Rogers Has Busy Third Quarter Nov 12 2014|
|Hanger: A favorable aging demography trend Sep 08 2014|
|Hanger Orthopedic Group Inc. Reports Operating Results (10-K) Mar 11 2011|
|Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 26,000 Sh Feb 28 2011|
|John Keeley Buys CAR, HGR, NCR, DAN, SKS, FELE, NWBI, FII, MF, HHC Feb 09 2011|
|Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 30,000 Sh Nov 22 2010|
|Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 10,030 Shares Nov 18 2010|
|Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 1,525 Sha Nov 18 2010|
|Hanger Orthopedic Group Inc. (HGR) President and CEO Thomas F Kirk sells 11,458 Shares Aug 13 2010|
|Hanger Orthopedic Group Inc. (HGR) Executive Vice President, CFO George E Jr Mchenry sells 3,348 Sha Aug 13 2010|